Related references
Note: Only part of the references are listed.The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study
Stavros Gravas et al.
WORLD JOURNAL OF UROLOGY (2019)
Combined Sabal and Urtica Extracts (WS® 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia
Natascha Pigat et al.
FRONTIERS IN PHARMACOLOGY (2019)
Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8+ T cells in benign prostatic hyperplasia
Song Jin et al.
PROSTATE (2019)
Comparison of the Phytochemical Composition of Serenoa repens Extracts by a Multiplexed Metabolomic Approach
Guillaume Marti et al.
MOLECULES (2019)
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies
Remigio Vela-Navarrete et al.
BJU INTERNATIONAL (2018)
Effect of tadalafil on chronic pelvic pain and prostatic inflammation in a rat model of experimental autoimmune prostatitis
Ken Okamoto et al.
PROSTATE (2018)
Intraprostatic Reflux of Urine Induces Inflammation in a Rat
Yasuhito Funahashi et al.
PROSTATE (2017)
Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone
Luca Boeri et al.
SCIENTIFIC REPORTS (2017)
Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links
Q. He et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Mauro Gacci et al.
EUROPEAN UROLOGY (2016)
Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment-the QUALIPROST study
Antonio Alcaraz et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention
J. Curtis Nickel et al.
JOURNAL OF UROLOGY (2016)
Inflammatory mediators in the development and progression of benign prostatic hyperplasia
Cosimo De Nunzio et al.
NATURE REVIEWS UROLOGY (2016)
Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials
Giacomo Novara et al.
EUROPEAN UROLOGY FOCUS (2016)
How to Choose the Right Serenoa repens Extract
Francesco Scaglione
EUROPEAN UROLOGY SUPPLEMENTS (2015)
Comparison of the Effects of Hexanic Extract of Serenoa repens (Permixon) and Tamsulosin on Inflammatory Biomarkers in the Treatment of Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms
Grégoire Y. Robert
EUROPEAN UROLOGY SUPPLEMENTS (2015)
Effect of Serenoa Repens on Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia
Juventino I. I. I. Colado-Velazquez et al.
PHYTOTHERAPY RESEARCH (2015)
Anti-Inflammatory Properties of Lipidosterolic Extract of Serenoa Repens (Permixon®) in a Mouse Model of Prostate Hyperplasia
Sophie Bernichtein et al.
PROSTATE (2015)
Effects of hexanic extract of serenoa repens (permixon® 160mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
Alain Latil et al.
PROSTATE (2015)
Comparison of Tamsulosin Plus Serenoa Repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study
Young Woo Ryu et al.
UROLOGIA INTERNATIONALIS (2015)
Histologic Evaluation of Human Benign Prostatic Hyperplasia Treated by Dutasteride: A Study by Xenograft Model With Improved Severe Combined Immunodeficient Mice
Akira Tsujimura et al.
UROLOGY (2015)
The role of prostatic inflammation biomarkers in the diagnosis of prostate diseases
Razvan Bardan et al.
CLINICAL BIOCHEMISTRY (2014)
Prevalence of Inflammation and Benign Prostatic Hyperplasia on Autopsy in Asian and Caucasian Men
Alexandre R. Zlotta et al.
EUROPEAN UROLOGY (2014)
Effects of prostatic inflammation on LUTS and alpha blocker treatment outcomes
Ha Na Lee et al.
INTERNATIONAL BRAZ J UROL (2014)
The Role of Inflammation in Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) and Its Potential Impact on Medical Therapy
Vincenzo Ficarra et al.
CURRENT UROLOGY REPORTS (2014)
The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)
Giorgio Gandaglia et al.
BJU INTERNATIONAL (2013)
Is chronic prostatic inflammation a new target in the medical therapy of lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH)?
Vincenzo Ficarra
BJU INTERNATIONAL (2013)
Correlation between benign prostatic hyperplasia and inflammation
Yakup Bostanci et al.
CURRENT OPINION IN UROLOGY (2013)
Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
Nanor Sirab et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Interleukin 8 and the male genital tract
Francesco Lotti et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2013)
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit
Annamaria Morelli et al.
PROSTATE (2013)
PDE5 inhibitors blunt inflammation in human BPH: A potential mechanism of action for PDE5 inhibitors in LUTS
Linda Vignozzi et al.
PROSTATE (2013)
Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients: Orchestrated by Chronic Prostatic Inflammation and Prostatic Calculi?
Sang Hoon Kim et al.
UROLOGIA INTERNATIONALIS (2013)
Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro
Alain Latil et al.
BJU INTERNATIONAL (2012)
Serenoa repens for benign prostatic hyperplasia
James Tacklind et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate
Stephan P.J. van Vuuren et al.
BJU INTERNATIONAL (2011)
The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
Cosimo De Nunzio et al.
EUROPEAN UROLOGY (2011)
Effect of Serenoa repens, Lyocopene, and Selenium on Proinflammatory I kappa B-alpha Phenotype Activation: An In Vitro And In Vivo Comparison Study
Giulio Bonvissuto et al.
UROLOGY (2011)
The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia Treatment
Young Kee Kwon et al.
KOREAN JOURNAL OF UROLOGY (2010)
Should We Investigate Prostatic Inflammation for the Management of Benign Prostatic Hyperplasia?
Gregoire Robert et al.
EUROPEAN UROLOGY SUPPLEMENTS (2009)
Inflammation in Benign Prostatic Hyperplasia: A 282 Patients' Immunohistochemical Analysis
Gregoire Robert et al.
PROSTATE (2009)
Evaluation of Interleukin-8 in Expressed Prostatic Secretion as a Reliable Biomarker of Inflammation in Benign Prostatic Hyperplasia
Liangren Liu et al.
UROLOGY (2009)
The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial
J. Curtis Nickel et al.
EUROPEAN UROLOGY (2008)
Histologic Influence of Doxazosin and Finasteride in Benign Prostatic Hyperplasia Accompanying Chronic Inflammation
Dong Soo Park et al.
UROLOGIA INTERNATIONALIS (2008)
Examination of the relationship between symptoms of prostatitis and histological inflammation: Baseline data from the REDUCE chemoprevention trial
J. Curtis Nickel et al.
JOURNAL OF UROLOGY (2007)
Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?
Vibhash C. Mishra et al.
BJU INTERNATIONAL (2007)
Seminal plasma cytokines and chemokines in prostate inflammation: Interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia
Giuseppe Penna et al.
EUROPEAN UROLOGY (2007)
Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?
A Tuncel et al.
EUROPEAN UROLOGY (2005)
The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: Results from the MTOPS study
CG Roehrborn et al.
JOURNAL OF UROLOGY (2005)
Effects of androgen deprivation on chronic bacterial prostatitis in a rat model
SI Seo et al.
INTERNATIONAL JOURNAL OF UROLOGY (2003)
Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis
F Di Silverio et al.
EUROPEAN UROLOGY (2003)
BPH and inflammation: Pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay
RV Navarrete et al.
EUROPEAN UROLOGY (2003)
Comparison of a phytotherapeutic agent (Permixon) with an α-blocker (tamsulosin) in the treatment of benign prostatic hyperplasia:: A 1-year randomized international study
F Debruyne et al.
EUROPEAN UROLOGY (2002)
Share Paper
